Primary malignant melanoma of the epiglottis is extremely rare. Until now, only 4 cases have been reported in the world literature. We describ e a new case of epiglottic primary malignant melanoma in a 74-year-old man who presented with hoarseness and a fo reign-body sensation. Clinical examinatio n revealed the presence of a small, whitish, polypoid tumor on the laryngeal surface ofthe epiglottis; no other primal}' melanoma was detected. Wide excision ofthe lesion was performed, and microscopy revealed that it contained melanin -pigmented tumor cells in both the mu cosa and submucosa. Itnmunostaining was positi vefor 5-100 protein. The pat ient was treated with radiotherapy, and he remained well 1 yea r after the diagnosis with no evidence of recurrence.
Introduction
Mali gnant melanom a is a neopla sm that arises from melanocytes. Melan ocyt es are derived fro m the neural crest and are widely distr ibuted throughout all cutaneous and mucosal surfaces . Th ey are found in the basal layer of the epidermis near the derm al-epid erm al junction ; they have been reported in the laryn x, nasal cav ity, and mouth. I Although melanoma usuall y arises from the skin, in rare cases it ca n affect the eye, menin ges, and the muc ou s memb rane s of the digestive and upper respir atory tract.
Several varieties of epiglottic neop lasms have been described in the literature. Of these, malign ant melanoma is rare. When malignant melanoma of the epiglottis does occ ur, it ca n be either prim ary or seco ndary. Until now, only 4 cases of prim ary malignant melan om a of the epiglottis have been reported in the world literature.t? None of them were asso ciated with basal cell carc inoma. A case of a secondary amelanotic melanoma of the epiglottis was reported by Iked a et al in 1991 . 6 In this article, we report a 
Case report
A 74-year-old man present ed to the Departm ent of Laryngo logy and Otology at James Page t Hospit al with a 3-month history of hoar seness and an unu sual sensation in his throat. His medical history was significant for several recurr ent basal cell carcinomas of the head and neck (which had been treated with cryotherapy and excision) and for tuberculou s cer vical lymph adeniti s (fo r which he had received a full co urse of standard antituberculosis chem otherapy). He was a smoker and had been so for more than 40 years . Clinical exa minatio n did not reveal any cutaneous melanoma s or palpabl e cerv ical lymph nodes. Fibero ptic laryngoscopy detected a small, white, polypoid lesion on the posteri or aspec t of the epiglottis (figure I ). Und er genera l anes thesia, the patient under went direct laryngoscopy, and the lesion was exc ised and submitted for histopathologic exa mination. A paraffin sec tion stained with hematoxylin and eosi n (H&E) showed tumor cells with clear nuclei exhibiting pleomo rphi sm and melanin pigmentation in the cytopl asm (figure 2). Th ese cells had hyperchromatic nuclei, and they invaded both the mucosa and subm ucosa . On immunohi stochemi stry for S-l 00 protein, the tum or cells demo nstrated a strong positive staining in both the nuclei and cytoplasm (figure 3). The lesion was diagnosed as a prim ary malign ant melan oma because all cl inical, panendoscopic, and ophthalmo logic exa minat ions conducted to identi fy a possible primary lesion elsew here were negat ive. Following surgical exc ision, the patient opted to und ergo radiotherapy. One year after his diagn osis, he was we ll and showe d no evide nce of recurre nce.
Discussion
No case of malignant melanoma of the epiglottis has been published since 1991 . 6 Onl y 0.6 to 9.3 % of pati ents with cutaneous malignant melanoma will experience a metastasis to the muco sa ';f the upp er aerodigestive tract .? Mu cosal mel anom as are usuall y of the acral lent igin ous type," and they occ ur most often in the nasal cavi ty and sinuses (table 1),9A mong laryngeal melanom as, the suprag lottic regi on is the most com mo n site of involvem ent. 10 Cases of metastat ic me lano ma fro m an un kn own pri ma ry may be attributable to ( I) spontaneous regression of the primary, (2) the locat ion of a primary in a visceral org an, or (3) an inability to detect a prim ary in the skin.
Th e clinical features of laryn geal mel anom as include hoarseness, hem optysis, dysphagia, airw ay obstruc tion, and stridor.":" Enlarge d cervical lymph nodes ma y be prese nt. Th e tu mor can sprea d to the bra in, lungs, and spine." O ur pat ient presented with hoarseness and a forei gn-bod y se nsation. His hoarseness ma y have been attributable to chro nic laryngi tis secondary to his smoking. T he foreig n-bod y sensation disa ppeared after the tum or was excised .
A diagn osis of mel anom a mu st be co nfir med by histologi c exam ination of an excisiona l biop sy speci me n; obtaining a specimen might require direct laryngo scopy und er anesthe sia . Und er light microscopy, the tum or will ex hibit a pleom orphic e pithe lioid cell population of malign ant ce lls . Malignant spindle-shaped cell s may also be ident ified. Cells often co ntain dark-brown cy toplasmic and nucl ear rn elanin.t-F T he presence of mel an in is identi fiab le on H&E staining, Fo nta na staining, and immunoh istoche mistry, w hic h will sho w im muno reac tivity wit h S-l 00 pro tei n and HMB -45Y Elec tron microscopy may identify the presence of mel anosom es or pre melanosomes. Although the tum or in our patient appeared to be amelano tic on cl in ical examination, melanin pigm ent ation was see n in the cy to plas m on microscopy, and immunohisto logy was po siti ve for S-IOO protein .
Three co nditions usu all y exist that hel p identify a tum or as a primary malign ant melanom a : ( I) the tum or should be the dominant lesion , (2) there may be local and regiona l metastasis, and (3) the patien t should have no history of a primary cuta neous or ocular mel anoma or nevus that regressed spo nta neo usly." T he hallmark of a primary ma lignant mel anom a is the presence of junctional act ivity in the overly ing or adjacent mucosa." Malign ant cell s mu st be identified in the surface epithe lium to estab lish a diagnosis of a primary malignant rnelanoma.!' :" In our pa tie nt, mal ign ant ce lls wer e clearly see n in the surface epithe lium (figure 2). Our patient had no other ident ifiabl e mali gn an t lesion , and histol ogy of his previou s basal ce ll ca rcinomas did not provide any evidence of pigm ent ati on . T he refore, his tu mor was di agnosed as a pri mary.
Positron -em ission tom ography (PET) and magnetic resonance imag ing (MRI) may be used for stag ing malignant mel anom as. In a retrospective study of fluorodeoxygl ucose (FOG) PETi n 18 pat ient s with muc osal melanom a, Goerr es et al re port ed that all tum ors we re visible at stagi ng, but the FOG uptake was dependen t on the size and ana to mic site o f the lesion." Big nodular lesio ns wer e more vis ib le than the more superficial spread ing lesion s. Lesion s in the ante rior part of the nose were more di fficul t to detect than those located elsewhere. Yoshi oka et al an alyzed MRI findin gs in 6 patient s with mu cosal melan om a and found that on T I-weighted imagin g, 5 mel anomas we re hyp erinten se and I was isointen se. " On T 2-w eight ed imaging, S we re of mixed inte nsity and I was isointen se. Th e mean sig nal inten sity ra tios for the pr imary mel anom a to mu scle on T I-weigh ted imagi ng we re 1.51 wit h gado linium co ntras t and 1.39 witho ut it; the di fference was not sta tistica lly significant. Th is finding suggests that hyp erint ensit y on T l -wei ght ed imag ing is a co mmo n charac te ristic of mu cosal mel anoma but not a un iversal findi ng.
Th e only cura tive treatm ent is rad ical local excision (total laryngectom y and neck dissecti on for laryn geal mel anom a)." Local rec urrences are co m mo n, eve n whe n surg ical margin s are wide. A simple local exc ision is occasiona lly used . T he re is I repor t in the literature of a case of melan om a of the right vocal fold that was managed with a right cordectomy and adj uva nt radio thera py. IXTh at patient remained we ll witho ut an y ev ide nce of local rec urrence or met astasis for mor e than 3 yea rs. In the case describ ed by Iked a et al, a pat ient wi th cuta neo us am el an ot ic melanom a developed a me tas ta tic tumo r tha t invo lve d the epiglottis; the tum or was successfully excised via an intraoral approach and KTP/5 32 laser surgery ."
Nonsur gical treatments incl ude rad ioth erapy, che motherap y, immuno therapy, and CO 2 laser ablatio n.' ?Several repo rts publi shed during the past decade on radiotherapy alo ne have documented co mplete response rate s of 50 to 75 % and enduring lon g-term co ntrol in one-ha lf to twothi rds of the co mplete responders.Pr" Th ese da ta, taken in conj unctio n with the high rate of local fai lure after surgery alone, suggest that radi oth erapy wou ld have a useful rol e as a surg ica l adj uva nt in a co mbined-mo da lity ap proach, as we ll as being of va lue in the pr imary managem ent of unr esect able disease.P-" C ur re ntly, che mo the ra py is prin cipall y used fo r the trea tme nt of dissem inated disease and for pall iation ." Immunoth er apeu tic optio ns incl ude OK-432 , inter le ukin 2, lym ph okin e-acti vated killer ce lls, and cyc lop hos phamide ." Th e A me rica n Joint Co m mittee on Ca nce r co nd ucted a large co hort study of 734 pat ient s with stage I to III melanoma and found that bacill e Ca lmetre-Gu erin (BC G) vacc ine as an adjuva nt to dacarbaz ine de layed the progression of disease and improved survival." BCG vacci nation usuall y lowers the risk of developin g mel an om a." Sever al reason s ex plain the poor progn osis assoc iated with mu cosal melan om a: (I) the non sp ecific na ture of its sy mpto ms leads to de lays in dia gn osis, (2) the tum or affec ts man y olde r people w hose immune functio n is inefficie nt, (3) the rich vascular and lym pha tic effere nts of the mu cosa favor ea rly metastasis, and (4) mu cosal mel anom a is histologicall y aggressive. 1.25-27Even so, overall mortal ity fo r ea rly head and neck mel an om a has actua lly declined becau se a high er percent age of patien ts are seeking treatment whe n the tum or is at an ea rly stage (ta ble 2) .2X
